PitchSend

Cumberland Pharmaceuticals Pitch Deck

CALDOLOR R Pre-empt post-op pain Patented, injectable formulation of ibuprofen Developed and registered by Cumberland First injectable approved in the US for pain & fever Unresolved pain remains leading cause for hospital readmissions, with a total market potential of over 700M units* • Significant data supports pre-op management of inflammation Pediatric labeling approved by FDA and launched Next Generation product approved and prepping for launch *Symphony Source Health 7 Have you given CALDOLOR yet? Choose MAKE THE DECISION BEFORE INCISION CALDOLOR (ibuprofen) Injection Please see attached full Prescribing information including Boed Warning

View entire presentation